Viewing Study NCT03406156


Ignite Creation Date: 2025-12-24 @ 11:29 PM
Ignite Modification Date: 2025-12-25 @ 9:16 PM
Study NCT ID: NCT03406156
Status: COMPLETED
Last Update Posted: 2024-08-06
First Post: 2018-01-16
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Subjects, Excluding Those With the 17p Deletion, to Evaluate Debulking Regimens Prior to Initiating Venetoclax Combination Therapy
Sponsor: AbbVie
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-08-10
Start Date Type: ACTUAL
Primary Completion Date: 2021-10-12
Primary Completion Date Type: ACTUAL
Completion Date: 2023-07-12
Completion Date Type: ACTUAL
First Submit Date: 2018-01-16
First Submit QC Date: None
Study First Post Date: 2018-01-23
Study First Post Date Type: ACTUAL
Results First Submit Date: 2022-10-07
Results First Submit QC Date: None
Results First Post Date: 2022-11-03
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-07-10
Last Update Post Date: 2024-08-06
Last Update Post Date Type: ACTUAL